Carson Wealth (CWM LLC)
RPTX

Carson Wealth (CWM LLC)’s Repare Therapeutics RPTX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$3K Hold
100
– – ﹤0.01% 2555
2021
Q1 		$3K Hold
100
– – ﹤0.01% 2554
2020
Q4 		$3K Hold
100
– – ﹤0.01% 2554
2020
Q3 		$3K Hold
100
– – ﹤0.01% 2553
2020
Q2 		$3K Buy
+100
New +$3.21K ﹤0.01% 2552

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RPTX Position: Q2 2021 in Review

Carson Wealth (CWM LLC) held its Repare Therapeutics (RPTX) position steady in Q2 2021 at 100 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #2555.

Carson Wealth (CWM LLC) first reported a position in RPTX in Q2 2020 and has held it in 5 quarters since. 61 funds tracked by Wall St. Rank hold RPTX as of Q2 2021.

  • Carson Wealth (CWM LLC) held 100 shares of Repare Therapeutics worth $3K as of Q2 2021.
  • Carson Wealth (CWM LLC) left its Repare Therapeutics share count unchanged in Q2 2021.
  • Repare Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q2 2021, its #2555 holding.
  • Carson Wealth (CWM LLC) first reported a position in Repare Therapeutics in Q2 2020 and has held it in 5 quarters since.
  • 61 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2021.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2021, filed 29 Jul 2021.